Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic is not ...

Novo Nordisk’s GLP-1 agonist Victoza has become the first non-insulin drug to be approved in the US as a treatment for type 2 diabetes in children for almost two decades.

Bengaluru: Biocon Limited, a global biopharmaceutical company, has announced that the company has received approval in India ...

The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. They were originally developed to treat type 2 diabetes, which happens ...

Biotech firm Biocon on Tuesday said it has received approval from the government authorities for a generic diabetes ...

Biocon has received approval in India for its generic version of Victoza, marking its first GLP-1 diabetes therapy clearance ...

Biocon shares are in focus as the company has received regulatory approval from the Central Drugs Standard Control ...